Eurizon trims Merck stake 7.3% but keeps $325 million
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Eurizon Capital SGR cut its Merck & Co. stake by 7.3% in the third quarter, selling 174,489 shares while retaining over 2.22 million shares worth roughly $325 million. Merck beat quarterly estimates with $2.49 per share in earnings and Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context